These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 141906)

  • 41. [Antitumor activities of oily suspended YM881 (SMANCS) against VX2 carcinoma].
    Kimura M; Konno T; Ohtsuka N; Mizumachi R; Oda T
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2183-8. PubMed ID: 2544148
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phase II trial of neocarzinostatin in patients with bladder and prostatic cancer: toxicity of a five-day iv bolus schedule.
    Natale RB; Yagoda A; Watson RC; Stover DE
    Cancer; 1980 Jun; 45(11):2836-42. PubMed ID: 6445776
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bladder tissue pharmacokinetics and antitumor effect of intravesical 5-fluorouridine.
    Song D; Wientjes MG; Gan Y; Au JL
    Clin Cancer Res; 1997 Jun; 3(6):901-9. PubMed ID: 9815765
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.
    Matsumura Y; Maeda H
    Cancer Res; 1986 Dec; 46(12 Pt 1):6387-92. PubMed ID: 2946403
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular mechanism of novel DNA sugar damage by an antitumour protein antibiotic.
    Goldberg IH; Kappen LS; Povirk LF; Chin DH
    Drugs Exp Clin Res; 1986; 12(6-7):495-505. PubMed ID: 2943568
    [TBL] [Abstract][Full Text] [Related]  

  • 46. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Experimental and clinical studies on the formation of antibodies to neocarzinostatin, a new protein antibiotic.
    Sakamoto S; Maeda H; Matsumoto T; Ogata J
    Cancer Treat Rep; 1978 Dec; 62(12):2063-70. PubMed ID: 156066
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vivo antitumor activity of neocarzinostatin (NCS)-tumor antibody conjugate against a transplantable human leukemia cell line (BALL-1).
    Kimura I; Tsubota T; Ohnoshi T; Sato Y; Okazaki M; Manabe Y; Abe S
    Jpn J Clin Oncol; 1983 Jun; 13(2):425-33. PubMed ID: 6224954
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Use of arterial infusion of neocarzinostatin with or without combination chemotherapy as a treatment of carcinoma of the prostate].
    Yuasa M; Numata A; Tanaka T; Kawanishi Y; Yamamoto A; Imagawa A
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2325-30. PubMed ID: 2425748
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Induced formation of a DNA bulge structure by a molecular wedge ligand-postactivated neocarzinostatin chromophore.
    Gao X; Stassinopoulos A; Ji J; Kwon Y; Bare S; Goldberg IH
    Biochemistry; 2002 Apr; 41(16):5131-43. PubMed ID: 11955061
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Radioimmunoassay of neocarzinostatin, an antitumor protein.
    Samy TS; Raso V
    Cancer Res; 1976 Dec; 36(12):4378-81. PubMed ID: 63321
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reduction of hepatic metastases in rabbits by administration of an oily anticancer agent into the portal vein.
    Yamasaki K; Konno T; Miyauchi Y; Maeda H
    Cancer Res; 1987 Feb; 47(3):852-5. PubMed ID: 3026619
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Immunoresponses and efficacy after arterial infusion of immunoconjugate A7-NCS in patients with colon cancer].
    Honda M; Yamaguchi T; Ohtsuji E; Noguchi A; Chimori Y; Doi M; Kamiguchi M; Noguchi A; Kitamura K; Yokota T
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1811-4. PubMed ID: 2143891
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Targeting of doxorubicin to the urinary bladder of the rat shows increased cytotoxicity in the bladder urine combined with an absence of renal toxicity.
    Haas M; Moolenaar F; Elsinga A; Van der Wouden EA; de Jong PE; Meijer DK; de Zeeuw D
    J Drug Target; 2002 Feb; 10(1):81-9. PubMed ID: 11996090
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The absorption of doxorubicin and mitomycin C in perioperative instillation. An experimental and clinical study.
    Jauhiainen K; Eksborg S; Kangas L; Perilä M; Alfthan O
    Eur Urol; 1985; 11(4):269-72. PubMed ID: 3930252
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of succinyl neocarzinostatin in vivo.
    Maeda H; Ichimura H; Satoh H; Ohtsuki K
    J Antibiot (Tokyo); 1978 May; 31(5):468-72. PubMed ID: 149781
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An antitumor polypeptide antibiotic neocarzinostatin: the mode of apo-protein--chromophore interaction.
    Edo K; Saito K; Akiyama-Murai Y; Mizugaki M; Koide Y; Ishida N
    J Antibiot (Tokyo); 1988 Apr; 41(4):554-62. PubMed ID: 2967272
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synergistic Anti-glioma Effects in Vitro and in Vivo of Enediyne Antibiotic Neocarzinostatin and Paclitaxel via Enhanced Growth Delay and Apoptosis-Induction.
    Tianqin G; Chunlei C; Jingjing W
    Biol Pharm Bull; 2016 Oct; 39(10):1623-1630. PubMed ID: 27431785
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antitumour activity of an immunoconjugate composed of anti-human astrocytoma monoclonal antibody and neocarzinostatin.
    Kondo S; Nakatsu S; Sakahara H; Kobayashi H; Konishi J; Namba Y
    Eur J Cancer; 1993; 29A(3):420-3. PubMed ID: 8398344
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Intra-operative administration of neocarzinostatin into the duodenal subserosa and levels found in the regional lymph nodes in pancreato-duodenal cancer].
    Hase Y; Kondo T; Nakagawa H; Matsumoto T; Maekawa T; Sakakibara N
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3119-24. PubMed ID: 2960268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.